While use of antivirals would be an important treatment strategy for dengue, drugs that target certain immune mediators, such as leukotrienes, chymase, tryptase, platelet activating factor, growth factors, cytokines and other lipid mediators would be of potential benefit. Here, CMA1 is linked to dengue disease.